Scarica l'app Stockscreener
125.88
20.01%
-31.48
Precedente Chiudi:
$157.36
Aprire:
$141.35
Volume 24 ore:
4.14M
Relative Volume:
6.91
Capitalizzazione di mercato:
$6.92B
Reddito:
$360.35M
Utile/perdita netta:
$-149.57M
Rapporto P/E:
-42.53
EPS:
-2.96
Flusso di cassa netto:
$-81.27M
1 W Prestazione:
-17.83%
1M Prestazione:
-21.00%
6M Prestazione:
-3.17%
1 anno Prestazione:
+35.66%
Intervallo 1D:
$124.95
$142.95
Intervallo di 1 settimana:
$124.95
$161.78
Portata 52W:
$83.90
$163.71
Glaukos Corporation Stock (GKOS) Company Profile
Nome
Glaukos Corporation
Settore
Industria
Telefono
949-367-9600
Indirizzo
1 GLAUKOS WAY, ALISO VIEJO, CA
Confronta GKOS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GKOS
Glaukos Corporation
|
125.88 | 6.92B | 360.35M | -149.57M | -81.27M | -2.96 |
|
ABT
Abbott Laboratories
|
134.92 | 234.01B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.49 | 154.20B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
382.78 | 146.06B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.94 | 115.42B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.30 | 43.23B | 5.72B | 4.17B | 490.10M | 6.97 |
Glaukos Corporation Stock (GKOS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-19 | Aggiornamento | Mizuho | Neutral → Outperform |
| 2024-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-12-06 | Iniziato | UBS | Buy |
| 2024-12-02 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2024-07-10 | Downgrade | Citigroup | Buy → Neutral |
| 2024-05-06 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-12-21 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-12-04 | Iniziato | Morgan Stanley | Equal-Weight |
| 2023-11-28 | Iniziato | Truist | Buy |
| 2023-11-08 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-06-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-12-22 | Iniziato | Mizuho | Neutral |
| 2022-12-19 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2022-12-12 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-10-14 | Ripresa | Stephens | Overweight |
| 2022-10-04 | Iniziato | Needham | Buy |
| 2022-07-12 | Aggiornamento | Stifel | Hold → Buy |
| 2022-02-03 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2022-01-19 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-01-18 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2021-11-03 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2021-07-26 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2021-07-20 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2021-07-14 | Downgrade | Oppenheimer | Outperform → Perform |
| 2021-07-14 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-04-08 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-01-29 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | Aggiornamento | Citigroup | Sell → Neutral |
| 2020-12-09 | Iniziato | Oppenheimer | Perform |
| 2020-11-17 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2020-10-08 | Downgrade | JP Morgan | Neutral → Underweight |
| 2020-06-15 | Iniziato | Jefferies | Hold |
| 2020-03-05 | Iniziato | Citigroup | Sell |
| 2020-02-28 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-01-06 | Aggiornamento | Berenberg | Hold → Buy |
| 2019-12-12 | Downgrade | Wells Fargo | Outperform → Underperform |
| 2019-09-30 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2019-03-08 | Iniziato | BTIG Research | Neutral |
| 2018-08-30 | Iniziato | Berenberg | Hold |
| 2018-08-29 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-08-03 | Reiterato | Stifel | Hold |
| 2018-06-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2018-04-13 | Downgrade | Stifel | Buy → Hold |
| 2018-03-01 | Reiterato | Cantor Fitzgerald | Buy |
| 2017-03-02 | Reiterato | Cantor Fitzgerald | Overweight |
| 2017-01-06 | Aggiornamento | Stifel | Hold → Buy |
| 2016-10-27 | Iniziato | Wells Fargo | Outperform |
Mostra tutto
Glaukos Corporation Borsa (GKOS) Ultime notizie
Glaukos Corporation (NYSE:GKOS) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year - Simply Wall St
Glaukos Reports Record Sales Growth in Fourth Quarter of 2024, Announces 2025 Guidance - Vision Monday
Glaukos Q4 2024 Earnings Preview - MSN
Glaukos Corp. Reports Record Sales in Earnings Call - TipRanks
Glaukos Corp earnings missed by $0.02, revenue topped estimates - Investing.com India
Earnings call transcript: Glaukos Corp Q4 2024 sees revenue rise but EPS miss - Investing.com Nigeria
Truist maintains buy on Glaukos stock, price target steady at $185 By Investing.com - Investing.com South Africa
GKOS Stock Falls Despite Q4 Earnings & Revenue Beat, Margins Decline - MSN
Glaukos Delivers Mixed Q4 Results, Analyst Sees Growing Investor Interest During Transition - Benzinga
Truist maintains buy on Glaukos stock, price target steady at $185 - Investing.com
BTIG cuts Glaukos stock price target to $155 from $157 By Investing.com - Investing.com Nigeria
Glaukos Corporation (NYSE:GKOS) Q4 2024 Earnings Call Transcript - Insider Monkey
Glaukos price target raised to $160 from $153 at Wells Fargo - TipRanks
BTIG cuts Glaukos stock price target to $155 from $157 - Investing.com UK
Glaukos Corp (GKOS) Q4 2024 Earnings Call Highlights: Record Sales and Strategic Growth Amid ... - Yahoo Finance
Glaukos Announces Fourth Quarter and Full Year 2024 Financial Results - BioSpace
Glaukos Corporation Reports Strong 2024 Financial Results - TipRanks
Insider Selling: Glaukos Co. (NYSE:GKOS) Insider Sells 3,416 Shares of Stock - MarketBeat
Why Glaukos Stock is Soaring: Key Insights - TipRanks
Glaukos: Q4 Earnings Snapshot - Thehour.com
Glaukos Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Glaukos (GKOS) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Glaukos shares tumble 12% on wider-than-feared Q4 loss - Investing.com
Glaukos shares tumble 12% on wider-than-feared Q4 loss By Investing.com - Investing.com Australia
Glaukos Q4 Non-GAAP Loss Narrows, Sales Rise -February 20, 2025 at 04:37 pm EST - Marketscreener.com
Glaukos: Q4 Earnings Snapshot -February 20, 2025 at 05:52 pm EST - Marketscreener.com
Glaukos Reports Record Sales and Positive Revenue Outlook - TipRanks
Earnings Flash (GKOS) GLAUKOS CORPORATION Posts Q4 Loss $-0.40 Per Share, vs. FactSet Est of $-0.38 - Marketscreener.com
What To Expect From Glaukos Corp (GKOS) Q4 2024 Earnings - Yahoo Finance
Glaukos (NYSE:GKOS) Upgraded by Mizuho to Outperform Rating - MarketBeat
Glaukos Co. (NYSE:GKOS) Stock Holdings Trimmed by New York State Common Retirement Fund - MarketBeat
Glaukos Co. (NYSE:GKOS) Shares Sold by Peregrine Capital Management LLC - MarketBeat
Glaukos chief development officer Navratil sells $502,630 in stock - Investing.com India
Glaukos Stock Soars on Promising iDose Outlook - TipRanks
Mizuho Upgrades Glaukos (GKOS) - Nasdaq
This NetApp Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday - Benzinga
Glaukos rises after Mizuho upgrades rating to 'outperform' - TradingView
What to Expect From These 3 MedTech Stocks This Earnings Season? - Yahoo Finance
Allspring Global Investments Holdings LLC Lowers Position in Glaukos Co. (NYSE:GKOS) - MarketBeat
Truist maintains Buy on Glaukos stock with $185 target - MSN
Truist maintains Buy on Glaukos stock with $185 target By Investing.com - Investing.com Australia
What Analyst Projections for Key Metrics Reveal About Glaukos (GKOS) Q4 Earnings - Nasdaq
Legato Capital Management LLC Boosts Stock Holdings in Glaukos Co. (NYSE:GKOS) - MarketBeat
(GKOS) Investment Report - Stock Traders Daily
Glaukos (GKOS) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Here's Why You Should Retain Glaukos Stock in Your Portfolio Now - MSN
Glaukos Co. (NYSE:GKOS) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Glaukos (GKOS) Expected to Announce Earnings on Thursday - Defense World
Glaukos Corp. to Host Earnings Call - ACCESS Newswire
Peering Into Glaukos's Recent Short Interest - Benzinga
Glaukos Corporation Azioni (GKOS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.16%
0.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):